CoChat

Fibrate therapy and renal function

Sica, Domenic A. · 2009 · Current Atherosclerosis Reports

The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.

Abstract

Fibrates are a class of lipid-lowering medications primarily used as second-line agents behind statins. The adverse-effect profile of fibrates has been marked by a puzzling yet reversible rise in serum creatinine values with their use. It is not known whether this finding represents a true change in renal function. One proposed explanation for this phenomenon is that fibrates increase the production of creatinine, in which case a rise in serum creatinine values would not represent a true deterioration in renal function. An alternative theory is that fibrates reduce the production of vasodilatory prostaglandins, which would lead to a true change in renal function in patients who experience a rise in serum creatinine values. Routine serum creatinine monitoring is advisable in fibrate-treated patients, particularly in those with preexisting renal disease. A 30% increase in serum creatinine values in the absence of other causes of serum creatinine change warrants discontinuation of fibrate therapy. Serum creatinine values can take several weeks to return to their baseline values following discontinuation of a fibrate.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11883-009-0051-5

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Cited by

See all 34

Metadata

Authors
Sica, D. A.
Affiliations
Virginia Commonwealth University (US)
Corresponding author
Sica, Domenic A.
Venue
Current Atherosclerosis Reports
Published
2009-08-01
Volume
11
Issue
5
Pages
338-342
ISSN
  • 1523-3804 (ISSN-L)
  • 1534-6242
OpenAlex
W1988933322
Cited by
33
References
45
Citations by year
2025: 4 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 4 · 2016: 2 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
0.27
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Atherosclerosis Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
fibrates, renal function, serum creatinine, prostaglandins, drug-induced nephrotoxicity, lipid-lowering therapy, statins, creatinine monitoring, drug discontinuation
MeSH terms
Animals, Clofibric Acid, Creatinine, Glomerular Filtration Rate, Humans, Kidney, Treatment Outcome, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibrate therapy and renal function. https://app.cochat.ai/papers/10.1007/s11883-009-0051-5
The paper
Sica, D. A. (2009). Fibrate therapy and renal function. Current Atherosclerosis Reports. https://doi.org/10.1007/s11883-009-0051-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.